Advances in Cystic Fibrosis, An Issue of Clinics in Chest Medicine. The Clinics: Internal Medicine Volume 43-4

Table of Contents

Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations
Genetics of Cystic Fibrosis: Clinical Implications
Update on Innate and Adaptive Immunity in Cystic Fibrosis
Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis
Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators
The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation
Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis
Update on Clinical Outcomes of Highly Effective Modulator Therapy
Nontuberculous Mycobacterial Infections in Cystic Fibrosis
Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient
Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Transitions of Care in Cystic Fibrosis
Endocrine Complications of Cystic Fibrosis
Management of Mental Health in Cystic Fibrosis
Family Planning and Reproductive Health in Cystic Fibrosis
Update on Lung Transplantation for Cystic Fibrosis

Authors

Clemente J. Britto Assistant Professor of Medicine, Adult Cystic Fibrosis Program, Center for Pulmonary Infection Research and, Treatment (CPIRT) Section of Pulmonary, Critical Care & Sleep Medicine, Department of Internal Medicine. Jennifer L. Taylor-Cousar Medical Director, Clinical Research Services, Co-Director and CF TDC Director, Adult CF, Program, Professor, Departments of Medicine and Pediatrics, Divisions of Pulmonary, Critical Care and Sleep
Medicine and Pediatric Pulmonary Medicine
Divisions of Pulmonary Sciences and Critical Care
Medicine and Pediatric Pulmonology
University of Colorado Anschutz Medical Campus
National Jewish Health.